Showing 5871-5880 of 9381 results for "".
Physicians Have a Duty to Disobey
https://practicaldermatology.com/topics/practice-management/physicians-have-a-duty-to-disobey/24208/When I was in high school in the 1970s, we were required to read Henry David Thoreau’s essay, Civil Disobedience. We were taught that when confronted with something clearly wrong or unethical, it is our duty to stand up against it—even if it means not abiding by unjust laws or rules. We were to liveScurvy Following Gastric Bypass
https://practicaldermatology.com/issues/august-2025/scurvy-following-gastric-bypass/36701/This report highlights a unique case of scurvy presentation following gastric bypass surgery. A 39-year-old female presented for outpatient dermatology follow-up for a rash that had been present for several months, affecting the buttocks, extremities, and trunk.DermWireTV: Atopic Dermatitis Pipeline Watch, a Potential New Skin Cancer Treatment; Demystifying Itch, and the Premiere of PA Perspectives
https://practicaldermatology.com/topics/practice-management/dermwiretv-atopic-dermatitis-pipeline-watch-a-potential-new-skin-cancer-treatment-demystifying-itch-and-the-premiere-of-pa-perspectives/20228/Escient Pharmaceuticals, Rapt Therapeutics, and Connect Biopharma each report positive results from early clinical studies in AD. Finnish researchers discover a potential treatment for cutaneous squamous cell carcinoma in an existing chemotherapy drug. Research out of Harvard Medical School links ecA Bold New Future for Psoriatic Arthritis Treatments in Dermatology
https://practicaldermatology.com/topics/psoriasis/a-bold-new-future-for-psoriatic-arthritis-treatments-in-dermatology/60989/The current therapeutic landscape highlights the dermatologist’s role in PsA management.Combination Biologic and GLP-1 Receptor Agonist Therapy in Psoriasis
https://practicaldermatology.com/topics/psoriasis/combination-biologic-and-glp-1-receptor-agonist-therapy-in-psoriasis/60858/New evidence indicates benefits of a dual-treatment strategy for many patients.Antioxidants and Skin Cancer Risk: A Look at Vitamins A and B
https://practicaldermatology.com/topics/skin-cancer-photoprotection/antioxidants-and-skin-cancer-risk-a-look-at-vitamins-a-and-b/23106/There is some evidence to suggest that higher intake of these antioxidants may reduce skin cancer risks.Angioleiomyoma in a Rare Location
https://practicaldermatology.com/topics/other-dermatology/angioleiomyoma-in-a-rare-location/24012/A minimally invasive treatment is used to treat a tumor in a cosmetically sensitive area.Affirming the Benefits of Full Body Skin Exams… And Overcoming Obstacles
https://practicaldermatology.com/topics/general-topics/PD0909_08-php/22772/Dermatologist-initiated full body skin exams identify skin cancers when they are most treatable. So why are some patients still not receiving exams?Strength in Numbers: Assessing Your Financial Position
https://practicaldermatology.com/topics/practice-management/strength-in-numbers-assessing-your-financial-position/23863/Look at your ratios and ranges to make sure you are keeping up with industry—and economic—shifts.Comorbidities in Vitiligo
https://practicaldermatology.com/issues/august-2025/comorbidities-in-vitiligo/36702/Vitiligo is a chronic, acquired pigmentary disorder characterized by the progressive loss of function or destruction of melanocytes in the skin, hair follicles, and mucous membranes. In this piece, Dr. Brad Glick and colleagues explore comorbidities in vitiligo.